Study: Onglyza May Be Unsafe For Patients with Heart Issues

A Michigan Onglyza lawyer notes a study suggesting that the diabetes drug may be linked to heart failure for patients who already have heart problems. The U.S. Food and Drug Administration (FDA) has added a new warning to the drug’s label as a result of the study’s findings. Affected patients and their families may be eligible to seek compensation with the help of an Onglyza lawsuit attorney.

For more information, contact Attorney Group for Michigan today. Our consultations are free, confidential and without any obligation on your part. We can help answer your questions, and if you choose to pursue a claim we can connect you with an affiliated attorney who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

Researchers Suggest Onglyza Should Be Avoided By Patients with Heart Failure Risk

A study involving AstraZeneca’s type 2 diabetes medication Onglyza is making medical professionals and the FDA reevaluate how it should be prescribed and what warnings it should carry. According to BioPharmaDive, concerns about the drug’s link to heart failure are causing some members of the medical community to suggest it be avoided by type 2 diabetes patients with existing heart failure risk factors.

One diabetes physician who closely reviewed the study said that Onglyza patients most at risk for heart failure were those already suffering from conditions such as coronary artery disease, valvular heart disease and hypertension. The findings suggested by this and a related study were troubling enough to warrant changes at the federal level, with the FDA adding new warnings to the drug’s label following the urging of an FDA advisory committee. Another popular type 2 diabetes drug, Nesina, was the subject of the related study, and it, too, will adopt the new warning label, the website reported.

How a Michigan Onglyza Lawyer Can Help

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

Patients who are injured by Onglyza may be entitled to compensation for damages, including:

  • Medical expenses
  • The permanency of the injury
  • Pain, suffering, and mental anguish
  • Loss of income or ability to work

If a patient dies from complications after taking Onglyza, family members may be entitled to compensation for the wrongful death of their loved one, including:

  • Conscious pain and suffering of a loved one prior to death
  • Pain, suffering, and mental anguish from the loss of a loved one
  • Funeral expenses

Patients who have suffered severe side effects after taking Onglyza, as well as the families of those who have died as a result of complications with the drug, are encouraged to seek the advice of a Michigan Onglyza lawyer to learn more about their rights and remedies.

The Time You Have to Pursue a Claim is Limited. Contact Us Today.

For more information, contact Attorney Group for Michigan. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group for Michigan today.